Conmed (CNMD) Common Equity (2010 - 2026)
Conmed's (CNMD) quarterly Common Equity came in at $1.0 billion in Q2 2026, up 3.84% YoY from $1.0 billion in Q2 2025, and up 2.33% on a QoQ basis from $1.0 billion in Q1 2026.
Conmed (CNMD) Common Equity (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Common Equity data on file, last reported at $1.0 billion in Q2 2026.
- Quarterly Common Equity rose 3.84% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.0 billion (up 3.84% YoY) and the FY2025 annual result came in at $1.0 billion, up 7.31% from the prior year.
- Common Equity improved to $1.0 billion in Q2 2026, from $1.0 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.0 billion in Q2 2026 to a low of $673.0 million in Q2 2022.
- A 5-year average of $877.8 million and a median of $868.2 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity decreased 9.61% — and 2024, when it advanced 17.17%.
- Tracing CNMD's Common Equity over 5 years: stood at $745.5 million in 2022, then grew by 11.89% to $834.2 million in 2023, then gained by 15.4% to $962.7 million in 2024, then advanced by 7.31% to $1.0 billion in 2025, then advanced by 0.8% to $1.0 billion in 2026.
- The last three Common Equity figures came in at $1.0 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | 1.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.00 Bn |
| Mar 31, 2025 | 977.64 Mn |
| Dec 31, 2024 | 962.68 Mn |
| Sep 30, 2024 | 932.90 Mn |
| Jun 30, 2024 | 881.83 Mn |
| Mar 31, 2024 | 854.66 Mn |
| Dec 31, 2023 | 834.22 Mn |
| Sep 30, 2023 | 796.21 Mn |
| Jun 30, 2023 | 780.19 Mn |
| Mar 31, 2023 | 752.45 Mn |
| Dec 31, 2022 | 745.55 Mn |
| Sep 30, 2022 | 716.34 Mn |
| Jun 30, 2022 | 672.97 Mn |
| Mar 31, 2022 | 789.55 Mn |
| Dec 31, 2021 | 785.44 Mn |
| Sep 30, 2021 | 755.68 Mn |